Results 1 to 10 of about 9,116 (181)
Treatment ofMycobacterium abscessusInfection [PDF]
Emerging Infectious Diseases, 2016 Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effective drugs or dosing regimens are limited. To better identify treatment approaches and associated toxicities, we collected a series of case reports from the Emerging Infections Network. Side effects were common and often led to changing or discontinuing
Shannon A. Novosad +4 more
openaire +3 more sources
The heterogenous and diverse population of prophages in Mycobacterium genomes
mSystems, 2023 Bacterial genomes commonly carry one or more integrated prophages, although prophage prevalence varies greatly in different bacterial genera and species.
Lawrence Abad +4 more
doaj +1 more source
Respiratory Medicine Case Reports, 2017 Mycobacterium abscessus, which is ubiquitous environmental organism, is more likely to cause pulmonary infection in the presence underlying lung disease and immunosuppression.
Celestine Ishiekwene +5 more
doaj +1 more source
Etamycin as a Novel Mycobacterium abscessus Inhibitor [PDF]
International Journal of Molecular Sciences, 2020 The increase in drug-resistant Mycobacterium abscessus, which has become resistant to existing standard-of-care agents, is a major concern, and new antibacterial agents are strongly needed. In this study, we introduced etamycin that showed an excellent activity against M. abscessus.
Bui Thi Bich Hanh +8 more
openaire +2 more sources
Proposal that Mycobacterium massiliense and Mycobacterium bolletii be united and reclassified as Mycobacterium abscessus subsp. bolletii comb. nov., designation of Mycobacterium abscessus subsp. abscessus subsp. nov. and emended description of Mycobacterium abscessus [PDF]
International Journal of Systematic and Evolutionary Microbiology, 2011 The names ‘Mycobacterium abscessus subsp. abscessus’ and ‘Mycobacterium abscessus subsp. massiliense’, proposed by Leao et al. (2009, J Clin Microbiol 47, 2691–2698), cannot be validly published. The purpose of this report is to provide a description in accordance with the Rules of the Bacteriological Code (1990 Revision).
Leao, Sylvia Cardoso +3 more
openaire +3 more sources
Case Reports in Orthopedics, 2014 Mycobacterium abscessus infections rarely develop in healthy individuals, and mostly they occur in immunocompromised hosts. Vertebral osteomyelitis due to Mycobacterium abscessus is very rare and only three previous cases of spinal infection caused by ...
Satoshi Kato +7 more
doaj +1 more source
A Case of Multiple Skin Lesions After LipodissolveTM Injection
Annals of Internal Medicine: Clinical Cases, 2022 Mycobacterium abscessus (M. abscessus) is a rapidly growing nontuberculous mycobacterium commonly found in soil and water. It can cause localized infection when inoculated during surgical or cosmetic procedures.
Peihsuan R. Tsai +7 more
doaj +1 more source
Frontiers in Microbiology, 2022 Mycobacterium abscessus is a member of the non-tuberculous mycobacteria (NTM) group, responsible for chronic infections in individuals with cystic fibrosis (CF) or those otherwise immunocompromised. While viewed traditionally as an opportunistic pathogen,
Kia C. Ferrell +8 more
doaj +1 more source
Mycobacterium abscessus multispacer sequence typing [PDF]
BMC Microbiology, 2013 Abstract Background Mycobacterium abscessus group includes antibiotic-resistant, opportunistic mycobacteria that are responsible for sporadic cases and outbreaks of cutaneous, pulmonary and disseminated infections.
Sassi, Mohamed +2 more
openaire +4 more sources
Impact on Macrolide Resistance of Genetic Diversity of Mycobacterium abscessus Species
Microbiology Spectrum, 2022 Our previous study identified that the Mycobacterium abscessus subsp. abscessus T28 sequevar does not fully represent inducible macrolide resistance. Thus, we initiated a correlation study between genotypes and phenotypes.
Bor-En Jong +10 more
doaj +1 more source